Millennial Investing - The Investor’s Podcast Network - TIVP025: Smith & Wesson (SWBI): Deep Value — Locked and Loaded w/ Daniel Mahncke & Shawn O’Malley
Smith & Wesson (S&W) is the largest pistol manufacturer in the US, dominating a highly cyclical firearms market. The podcast episode explores an initial "contrarian value bet" thesis: S&W, despite being in a controversial industry often shunned by ESG-focused investors, might be undervalued due to its current position at a cyclical low, depressed by a one-time $180 million headquarters relocation and a slump in firearm sales.
The initial appeal stemmed from S&W's iconic brand, market leadership (20% pistol market share), and superior gross margins (38%+) compared to competitors like Sturm, Ruger. Historically, the stock has seen significant spikes (2x-6x) during periods of increased demand. The company also offers a ~5% dividend yield and has aggressively bought back shares, intending to return capital to shareholders while they wait for the next upturn. The investment idea was to buy when the stock is cheap due to depressed cyclical earnings and one-off CapEx (like the relocation, treated as non-growth maintenance CapEx), then benefit from the inevitable rebound.
Unlike typical business cycles, S&W's sales are primarily driven by political cycles (e.g., increased demand when Democrats are perceived to threaten gun rights), disaster preparedness (pandemics, social unrest), and reactions to highly publicized shootings. This makes the timing of surges unpredictable but historically inevitable.
However, a deeper dive revealed significant red flags. Management's compensation structure is poorly aligned with shareholders, focusing on adjusted operating earnings rather than per-share metrics. Despite its brand power, S&W has failed to diversify or monetize its intellectual property beyond manufacturing (e.g., licensing, training, media), indicating a lack of strategic vision and a culture that doesn't prioritize reinvention. This suggests it's an "okay business at best" rather than a "quality compounder."
Financial health is a major concern. The company's cash balance has plummeted to $26 million, far below its stated $100 million target, partly due to ill-timed share buybacks when the stock was expensive. Dividend payments consistently exceed 100% of free cash flow, raising questions about their sustainability. Inventory management suffers from demand volatility, leading to working capital pressure. The company also faces substantial regulatory and litigation risks (e.g., potential repeal of the Protection of Lawful Commerce in Arms Act), and even had to establish its own insurance company due to market reluctance to cover such a risky business.
Ultimately, the initial enthusiasm for the investment waned. While the "normalized" earnings yield might be attractive (around 10% after adjusting for cyclical lows and one-time CapEx), the combination of poor capital allocation, shaky dividend sustainability, weak cash position, and an unpredictable timeline for the next sales surge transforms S&W into a potential "value trap." The significant managerial and financial drawbacks overshadow the cyclical upside, making it unsuitable for a long-term, high-conviction portfolio, despite the intriguing "long social volatility" hedge aspect. The hosts conclude that while the high-level thesis was promising, verifying the assumptions reveals a poorly run business with substantial risks.